Treatment of hirsutism with myo-inositol: A prospective clinical study

Reproductive BioMedicine Online

Volumn 17, Issue 4, 2008, Pages 579-582

  Minozzi, M ^a   D'Andrea, G ^b   Unfer, Vittorio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Obstetrics and Gynecology Centre   (Italy)

Author keywords

HDL cholesterol; Insulin resistance; LDL cholesterol; Myo inositol; Total cholesterol; Triglycerides

Indexed keywords

ANDROGEN; APOLIPOPROTEIN B; CHOLESTEROL; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INOFOLIC; INOSITOL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 54449092873     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60248-9     Document Type: Article

References (16)

1. Azziz R 2004 PCOS: a diagnostic challenge. Reproductive BioMedicine Online 8, 644-648.
2. Azziz R 2003 The evaluation and management of hirsutism. Obstetrics and Gynecology 101, 995-1007.
3. Baillargeon JP 2005 Use of insulin sensitizers in polycystic ovarian syndrome. Current Opinion in Investigational Drugs 6, 1012-1022.
4. Baillargeon JP, Kandarakis ED, Ostlund RE et al. 2006 Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 29, 300-305.
5. Cheang KI, Nestler JE 2004 Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? Reproductive BioMedicine Online 8, 440-447.
6. Escobar-Morreale HF, Lasunción MA, Sancho J 2000 Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity. Fertility and Sterility 74, 816-819.
7. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology 21, 1440-1447.
8. Geisthövel F, Rabe T 2007 The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS): an extended critical analysis. Reproductive BioMedicine Online 14, 522-535.
9. Gerli S, Mignosa M, Di Renzo GC 2003 Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. European Review for Medical and Pharmacological Sciences 7, 151-159.
10. Iuorno MJ, Jacubowicz DJ, Baillargeon JP et al. 2002 Effect of D-chiro-inositol in lean women with the polycystic ovary syndrome. Endocrine Practice 8, 417-423.
11. Krauss RM, Burkman RT Jr 1992 The metabolic impact of oral contraceptives. American Journal of Obstetrics and Gynecology 167, 1177-1184.
12. Nestler JE, Jacubowicz DJ 1997 Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. Journal of Clinical Endocrinology and Metabolism 82, 4075-4079.
13. Nestler JE, Jakubowicz DJ, Reamer P et al. 1999 Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. New England Journal of Medicine 340, 1314-1320.
14. Papaleo E, Unfer V. Baillargeon JP et al. 2007 Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecologic Endocrinology 10, 1-4.
15. Proctor SD, Kelly SE, Vine DF, Russell JC 2007 Metabolic effects of a novel silicate inositol complex of the nitric oxide precursor arginine in the obese insulin-resistant. Metabolism 56, 1318-1325.
16. Yoshida K, Yamaguchi M, Morinaga T et al. 2006 Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigation drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome. Applied and Environmental Microbiology 72, 1310-1315.